Use of HIV Resistance Testing After Prolonged Treatment Interruption-Reference-Cited by-同舟云学术

Use of HIV Resistance Testing After Prolonged Treatment Interruption

Published:2010-03-01 Issue:3 Volume:53 Page:333-337
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Iarikov Dmitri E,Irizarry-Acosta Melina,Martorell Claudia,Rauch Carol A,Hoffman Robert P,Skiest Daniel J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference21 articles.

1. An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002.;Moore;J Acquir Immune Defic Syndr,2005

2. An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults.;Bartlett;AIDS,2006

3. Antoniou A, et al; CASCADE Collaboration. Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.;Touloumi;J Acquir Immune Defic Syndr,2006

4. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.;Holkmann Olsen;HIV Med,2007

5. Nonstructured treatment interruptions among injection drug users in Baltimore, MD.;Kavasery;J Acquir Immune Defic Syndr,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China;Pathogens;2021-02-25

2. Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions;HIV Medicine;2013-11-12

3. Evolution of Drug-Resistant Viral Populations during Interruption of Antiretroviral Therapy;Journal of Virology;2011-07

4. Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b;Journal of Viral Hepatitis;2011-03-01